Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

This Little-Known Stock Has Surged 550% in the Past Year

  • SELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading.
  • SLS currently has no revenue, with all products in development or clinical trials, making the stock highly speculative.
  • Technical indicators are overwhelmingly bullish, but high short interest highlights significant risk.
  • Sentiment is mixed: Barchart and Value Line are bullish, while Morningstar and Seeking Alpha rate SLS as “Hold” or suggest it is overvalued.

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.